PDB: 533 resultsInfo pagesStatus searchChemie searchBIRD

---

4J9E	Crystal structure of the N114A mutant of the Abl-SH3 domain complexed with the high affinity peptide P17 Descriptor: P17, SULFATE ION, Tyrosine-protein kinase ABL1 Authors: Camara-Artigas, A. Deposit date: 2013-02-16 Release date: 2014-01-29 Last modified: 2023-09-20 Method: X-RAY DIFFRACTION (1.4 Å) Cite: Crystal structure of the N114A mutant of the Abl-SH3 domain complexed with the high affinity peptide P17 To be Published
4J9B	Crystal structure of the Abl-SH3 domain H59Q-N96T mutant Descriptor: DI(HYDROXYETHYL)ETHER, Tyrosine-protein kinase ABL1 Authors: Camara-Artigas, A. Deposit date: 2013-02-16 Release date: 2014-01-29 Last modified: 2023-09-20 Method: X-RAY DIFFRACTION (1.702 Å) Cite: Crystal structure of the Abl-SH3 domain H59Q-N96T mutant To be Published
4J9D	Crystal structure of the N114A mutant of the Abl-SH3 domain complexed with the high affinity peptide P0 Descriptor: P0, SULFATE ION, Tyrosine-protein kinase ABL1 Authors: Camara-Artigas, A. Deposit date: 2013-02-16 Release date: 2014-01-29 Last modified: 2023-09-20 Method: X-RAY DIFFRACTION (1.5 Å) Cite: Crystal structure of the N114A mutant of the Abl-SH3 domain complexed with the high affinity peptide P0 To be Published
4J9H	Crystal structure of the ABL-SH3 domain complexed with the designed high-affinity peptide ligand P7 at pH 8 Descriptor: P7, SULFATE ION, Tyrosine-protein kinase ABL1 Authors: Camara-Artigas, A. Deposit date: 2013-02-16 Release date: 2014-01-29 Last modified: 2023-09-20 Method: X-RAY DIFFRACTION (1.7 Å) Cite: Crystal structure of the ABL-SH3 domain complexed with the designed high-affinity peptide ligand P7 To be Published
4J9C	Crystal structure of the Abl-SH3 domain H59Q-N96T mutant complexed with the designed high-affinity peptide ligand P17 Descriptor: DI(HYDROXYETHYL)ETHER, P17, TRIETHYLENE GLYCOL, ... Authors: Camara-Artigas, A. Deposit date: 2013-02-16 Release date: 2014-01-29 Last modified: 2023-09-20 Method: X-RAY DIFFRACTION (1.051 Å) Cite: Crystal structure of the Abl-SH3 domain H59Q-N96T mutant complexed with the designed high-affinity peptide ligand P17 To be Published
4J9G	Crystal structure of the ABL-SH3 domain complexed with the designed high-affinity peptide ligand P7 at pH7 Descriptor: GLYCEROL, P7, SULFATE ION, ... Authors: Camara-Artigas, A. Deposit date: 2013-02-16 Release date: 2014-01-29 Last modified: 2023-09-20 Method: X-RAY DIFFRACTION (1.8 Å) Cite: Crystal structure of the ABL-SH3 domain complexed with the designed high-affinity peptide ligand P7 To be Published
2M51	NMR structure of the SH3 domain of human RAS p21 protein activator (GTPase activating protein) 1 Descriptor: Ras GTPase-activating protein 1 Authors: Dutta, S.K, Serrano, P, Geralt, M, Wuthrich, K, Joint Center for Structural Genomics (JCSG), Partnership for T-Cell Biology (TCELL) Deposit date: 2013-02-12 Release date: 2013-03-27 Last modified: 2024-05-15 Method: SOLUTION NMR Cite: NMR structure of the SH3 domain of human RAS p21 protein activator (GTPase activating protein) 1 To be Published
4IIM	Crystal structure of the Second SH3 Domain of ITSN1 bound with a synthetic peptide Descriptor: Intersectin-1, UNKNOWN ATOM OR ION, peptide ligand Authors: Dong, A, Guan, X, Huang, H, Wernimont, A, Gu, J, Sidhu, S, Bountra, C, Arrowsmith, C.H, Edwards, A.M, Tong, Y, Structural Genomics Consortium (SGC) Deposit date: 2012-12-20 Release date: 2013-01-23 Last modified: 2023-09-20 Method: X-RAY DIFFRACTION (1.8 Å) Cite: Crystal structure of the Second SH3 Domain of ITSN1 bound with a synthetic peptide To be Published
4HXJ	Crystal structure of SH3:RGT complex Descriptor: C-terminal 3-mer peptide from Integrin beta-3, Proto-oncogene tyrosine-protein kinase Src Authors: Xiao, R, Meng, G. Deposit date: 2012-11-11 Release date: 2012-11-28 Last modified: 2023-11-08 Method: X-RAY DIFFRACTION (2 Å) Cite: Structural framework of c-Src activation by integrin beta 3 Blood, 121, 2013
2M0Y	Solution structure of the SH3 domain of DOCK180 Descriptor: Dedicator of cytokinesis protein 1 Authors: Liu, X, Wen, W. Deposit date: 2012-11-08 Release date: 2012-12-19 Last modified: 2024-05-15 Method: SOLUTION NMR Cite: Solution structure of the SH3 domain of DOCK180. Proteins, 81, 2013
4HVW	Crystal structure of the T98E c-Src-SH3 domain mutant in complex with the high affinity peptide VSL12 Descriptor: ACETYL GROUP, Proto-oncogene tyrosine-protein kinase Src, SULFATE ION, ... Authors: Camara-Artigas, A. Deposit date: 2012-11-07 Release date: 2013-05-01 Last modified: 2023-09-20 Method: X-RAY DIFFRACTION (0.98 Å) Cite: Atomic resolution structures of the c-Src SH3 domain in complex with two high-affinity peptides from classes I and II. Acta Crystallogr.,Sect.D, 69, 2013
4HVV	Crystal structure of the T98E c-Src-SH3 domain mutant in complex with the high affinity peptide APP12 Descriptor: Proto-oncogene tyrosine-protein kinase Src, SULFATE ION, SYNTHETIC PEPTIDE Acetyl-APPLPPRNRP Authors: Camara-Artigas, A. Deposit date: 2012-11-07 Release date: 2013-05-01 Last modified: 2023-09-20 Method: X-RAY DIFFRACTION (1.1 Å) Cite: Atomic resolution structures of the c-Src SH3 domain in complex with two high-affinity peptides from classes I and II. Acta Crystallogr.,Sect.D, 69, 2013
4HVU	Crystal structure of the T98D c-Src-SH3 domain mutant in complex with the high affinity peptide APP12 Descriptor: ACETYL GROUP, Proto-oncogene tyrosine-protein kinase Src, SULFATE ION, ... Authors: Camara-Artigas, A. Deposit date: 2012-11-07 Release date: 2013-05-01 Last modified: 2023-09-20 Method: X-RAY DIFFRACTION (0.98 Å) Cite: Atomic resolution structures of the c-Src SH3 domain in complex with two high-affinity peptides from classes I and II. Acta Crystallogr.,Sect.D, 69, 2013
2LZ6	Distinct ubiquitin binding modes exhibited by sh3 domains: molecular determinants and functional implications Descriptor: CD2-associated protein, Ubiquitin Authors: Ortega-Roldan, J, Azuaga, A, Blackledge, M, Van Nuland, N. Deposit date: 2012-09-24 Release date: 2013-10-02 Last modified: 2024-05-15 Method: SOLUTION NMR Cite: Distinct Ubiquitin Binding Modes Exhibited by SH3 Domains: Molecular Determinants and Functional Implications. Plos One, 8, 2013
4GLM	Crystal structure of the SH3 Domain of DNMBP protein [Homo sapiens] Descriptor: Dynamin-binding protein, UNKNOWN ATOM OR ION Authors: Dong, A, Guan, X, Huang, H, Tempel, W, Gu, J, Sidhu, S, Bountra, C, Arrowsmith, C.H, Edwards, A.M, Tong, Y, Structural Genomics Consortium (SGC) Deposit date: 2012-08-14 Release date: 2012-11-21 Last modified: 2023-09-13 Method: X-RAY DIFFRACTION (1.9 Å) Cite: Crystal structure of the SH3 Domain of DNMBP protein [Homo sapiens] to be published
4FSS	Crystal structure of a RAS p21 protein activator (RASA1) from Homo sapiens at 2.25 A resolution Descriptor: CHLORIDE ION, GLYCEROL, PHOSPHATE ION, ... Authors: Joint Center for Structural Genomics (JCSG), Partnership for T-Cell Biology (TCELL) Deposit date: 2012-06-27 Release date: 2012-07-18 Last modified: 2023-02-01 Method: X-RAY DIFFRACTION (2.25 Å) Cite: Crystal structure of a RAS p21 protein activator (RASA1) from Homo sapiens at 2.25 A resolution To be published
4F16	Crystal Structure of the alpha spectrin SH3 domain at pH 5 Descriptor: Spectrin alpha chain, brain Authors: Camara-Artigas, A, Gavira, J.A. Deposit date: 2012-05-06 Release date: 2013-05-08 Last modified: 2023-09-13 Method: X-RAY DIFFRACTION (1.93 Å) Cite: Crystal Structure of the alpha spectrin SH3 domain at pH 5 To be Published
4F17	Crystal Structure of the alpha spectrin SH3 domain at pH 9 Descriptor: Spectrin alpha chain, brain Authors: Camara-Artigas, A, Gavira, J.A. Deposit date: 2012-05-06 Release date: 2013-05-08 Last modified: 2023-09-13 Method: X-RAY DIFFRACTION (1.55 Å) Cite: Crystal Structure of the alpha spectrin SH3 domain at pH 9 To be Published
4ESR	Molecular and Structural Characterization of the SH3 Domain of AHI-1 in Regulation of Cellular Resistance of BCR-ABL+ Chronic Myeloid Leukemia Cells to Tyrosine Kinase Inhibitors Descriptor: DI(HYDROXYETHYL)ETHER, Jouberin Authors: Van Petegem, X.F, Liu, P.X, Lobo, P, Jiang, X. Deposit date: 2012-04-23 Release date: 2012-06-06 Last modified: 2024-02-28 Method: X-RAY DIFFRACTION (1.53 Å) Cite: Molecular and structural characterization of the SH3 domain of AHI-1 in regulation of cellular resistance of BCR-ABL(+) chronic myeloid leukemia cells to tyrosine kinase inhibitors. Proteomics, 12, 2012
3VS2	Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-[cis-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine Descriptor: 7-[cis-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, CALCIUM ION, CHLORIDE ION, ... Authors: Kuratani, M, Tomabechi, Y, Niwa, H, Parker, J.L, Handa, N, Yokoyama, S. Deposit date: 2012-04-21 Release date: 2013-05-01 Last modified: 2023-12-06 Method: X-RAY DIFFRACTION (2.609 Å) Cite: A Pyrrolo-Pyrimidine Derivative Targets Human Primary AML Stem Cells in Vivo Sci Transl Med, 5, 2013
3VRZ	Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea Descriptor: 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea, CALCIUM ION, CHLORIDE ION, ... Authors: Kuratani, M, Tomabechi, Y, Handa, N, Yokoyama, S. Deposit date: 2012-04-21 Release date: 2013-05-01 Last modified: 2023-12-06 Method: X-RAY DIFFRACTION (2.218 Å) Cite: A Pyrrolo-Pyrimidine Derivative Targets Human Primary AML Stem Cells in Vivo Sci Transl Med, 5, 2013
3VRY	Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 4-Amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl-cyclopentane Descriptor: 4-Amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl-cyclopentane, CALCIUM ION, CHLORIDE ION, ... Authors: Kuratani, M, Tomabechi, Y, Niwa, H, Handa, N, Yokoyama, S. Deposit date: 2012-04-21 Release date: 2013-05-01 Last modified: 2023-12-06 Method: X-RAY DIFFRACTION (2.481 Å) Cite: A Pyrrolo-Pyrimidine Derivative Targets Human Primary AML Stem Cells in Vivo Sci Transl Med, 5, 2013
3VS7	Crystal structure of HCK complexed with a pyrazolo-pyrimidine inhibitor 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Descriptor: 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, CALCIUM ION, CHLORIDE ION, ... Authors: Kuratani, M, Honda, K, Niwa, H, Toyama, M, Handa, N, Yokoyama, S. Deposit date: 2012-04-21 Release date: 2013-05-01 Last modified: 2023-12-06 Method: X-RAY DIFFRACTION (3.001 Å) Cite: A Pyrrolo-Pyrimidine Derivative Targets Human Primary AML Stem Cells in Vivo Sci Transl Med, 5, 2013
3VS1	Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-phenylurea Descriptor: 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-phenylurea, CALCIUM ION, CHLORIDE ION, ... Authors: Kuratani, M, Tomabechi, Y, Toyama, M, Handa, N, Yokoyama, S. Deposit date: 2012-04-21 Release date: 2013-05-01 Last modified: 2023-12-06 Method: X-RAY DIFFRACTION (2.464 Å) Cite: A Pyrrolo-Pyrimidine Derivative Targets Human Primary AML Stem Cells in Vivo Sci Transl Med, 5, 2013
3VS4	Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 5-(4-phenoxyphenyl)-7-(tetrahydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine Descriptor: 5-(4-phenoxyphenyl)-7-(tetrahydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, CALCIUM ION, CHLORIDE ION, ... Authors: Kuratani, M, Tomabechi, Y, Handa, N, Yokoyama, S. Deposit date: 2012-04-21 Release date: 2013-05-01 Last modified: 2023-12-06 Method: X-RAY DIFFRACTION (2.747 Å) Cite: A Pyrrolo-Pyrimidine Derivative Targets Human Primary AML Stem Cells in Vivo Sci Transl Med, 5, 2013

<234567891011121314151617>